Why was the Summary Basis of Decision initiative undertaken?
The SBD initiative was undertaken in response to Health Canada’s commitment to enhance the transparency of the drug and medical device review process. In the past, Canadian healthcare professionals frequently relied on foreign approval packages to obtain information about drugs and medical devices as there was no similar information disseminated in Canada. These foreign information sources may be inconsistent with Canadian regulatory decisions and may not provide information appropriate to the Canadian context.
